Full Text View
Tabular View
No Study Results Posted
Related Studies
Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis (SPARTA)
This study is currently recruiting participants.
Verified March 2012 by Glostrup University Hospital, Copenhagen
Study NCT00726804   Information provided by Glostrup University Hospital, Copenhagen

First Received on July 30, 2008.   Last Updated on March 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
SPONDYLOARTHRITIS
Additional conditions recognized in this trial
Spondylarthritis
More general conditions related to this trial
Arthritis
Bone Diseases
Joint Diseases
Musculoskeletal Diseases
Spinal Diseases
Spondylitis
Additional drug interventions recognized in this trial
Adalimumab
TNFR-Fc fusion protein
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Glostrup University Hospital, Copenhagen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services